SCHEMBL20012945

SCHEMBL20012945

COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(I)c(-n2ccnc2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ INSR P06213 10/20 0.62
▸ IGF1R P08069 10/20 0.62
▸ ALK Q9UM73 10/20 0.62
▸ LRRK2 Q5S007 3/20 0.58
▸ MAPK7 Q13164 1/20 0.58
▸ PTK2 Q05397 7/20 0.56
▸ PLK1 P53350 2/20 0.55
▸ PDGFRB P09619 1/20 0.55
▸ PDGFRA P16234 1/20 0.55
▸ DCLK1 O15075 1/20 0.54
▸ EGFR P00533 2/20 0.54
▸ CHEK1 O14757 1/20 0.54
▸ AURKA O14965 1/20 0.54
▸ NUAK1 O60285 1/20 0.54
▸ JAK2 O60674 1/20 0.54
▸ STK10 O94804 1/20 0.54
▸ PRKD3 O94806 1/20 0.54
▸ SLC34A2 O95436 1/20 0.54
▸ CHEK2 O96017 1/20 0.54
▸ ABL1 P00519 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20012920 0.91 TTK (0.57) INSRIGF1RALKLRRK2MAPK7
SCHEMBL20012909 0.87 PDGFRB (0.50) INSRIGF1RALKPDGFRBPDGFRA
SCHEMBL20012932 0.86 FGFR3 (0.58) EGFRFGFR1FGFR2FGFR4FGFR3
SCHEMBL20012902 0.85 INSR (0.60) INSRIGF1RALKLRRK2MAPK7
SCHEMBL15244473 0.81 INSR (0.68) INSRIGF1RALKLRRK2MAPK7
SCHEMBL18912630 0.78 INSR (0.68) INSRIGF1RALKLRRK2MAPK7
SCHEMBL30003588 0.78 INSR (0.65) INSRIGF1RALKLRRK2MAPK7
SCHEMBL26087590 0.77 ALK (0.73) INSRIGF1RALKLRRK2MAPK7
SCHEMBL20012904 0.77 CDK4 (0.54) INSRALKPDGFRBPDGFRAEGFR
SCHEMBL20012906 0.77 CDK4 (0.46) IGF1RPTK2AURKAJAK2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018056621-A1 NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 재단법인 대구경북첨단의료산업진흥재단 2018-03-29 — — WO disclosed
Send feedback